Research on skeletal muscle biopsies from DMD patients has revealed decreased NAD + levels, increased PARP activity 253 and dysfunction of mitochondrial metabolism 254,266
Clinics and telehealth companies jumped at the opportunity, offering these medications as a way to bypass waitlists and high prices
Not for clients with type 1 diabetes No history of medullary thyroid carcinoma or MEN 2 syndrome Not currently pregnant or breastfeeding No severe gastrointestinal disease No concurrent usage of other tirzepatide products or any GLP-1 receptor agonist It's easy to get started
Improved insulin response pancreatic beta cells release insulin more efficiently after meals, supporting steadier blood glucose levels and reducing the fat-storage signals driven by insulin spikes
Primary applications include treating B12 deficiency, supporting energy production, and maintaining neurological health
For further information about ingredient sourcing, pricing, general inquiries, or additional information regarding GLP-1 trends, please contact AIFI using the link below.